Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,708 | 58,169 | 67,142 | 59,172 | 71,722 |
| Marketable Securities | 106,513 | 122,924 | 135,701 | 145,803 | 149,680 |
| Other current assets | 2,443 | 2,493 | 2,551 | 3,108 | 3,326 |
| TOTAL | $192,490 | $205,820 | $230,702 | $242,314 | $263,454 |
| Non-Current Assets | |||||
| PPE Net | 285 | 304 | 321 | 344 | 359 |
| Intangibles | 16,836 | 16,836 | 16,836 | 16,836 | 16,836 |
| Other Non-Current Assets | 37,654 | 41,129 | 34,732 | 33,447 | 30,988 |
| TOTAL | $54,775 | $58,269 | $51,889 | $50,627 | $48,183 |
| Total Assets | $247,265 | $264,089 | $282,591 | $292,941 | $311,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,679 | 6,874 | 5,116 | 2,824 | 2,934 |
| Accrued Expenses | 7,151 | 8,738 | 7,524 | 4,297 | 6,501 |
| Other current liabilities | 5,270 | 1,471 | 3,146 | 1,515 | 5,200 |
| TOTAL | $21,000 | $17,587 | $16,280 | $9,120 | $15,109 |
| Non-Current Liabilities | |||||
| Long Term Debt | 142,397 | 142,086 | 141,774 | 141,461 | 128,210 |
| Other Non-Current Liabilities | 5,624 | 5,459 | 5,657 | 5,856 | 6,052 |
| TOTAL | $148,021 | $147,545 | $147,431 | $147,317 | $134,262 |
| Total Liabilities | $169,021 | $165,132 | $163,711 | $156,437 | $149,371 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,032 | 58,620 | 58,596 | 58,488 | 58,465 |
| Common Shares | 586 | 586 | 584 | 584 | 583 |
| Retained earnings | -447,756 | -425,455 | -403,453 | -383,872 | -384,187 |
| Other shareholders' equity | -23,940 | -22,744 | -22,350 | -22,306 | -21,051 |
| TOTAL | $78,244 | $98,957 | $118,880 | $136,504 | $162,266 |
| Total Liabilities And Equity | $247,265 | $264,089 | $282,591 | $292,941 | $311,637 |